Clair, a startup founded by Stanford graduates, is developing a wearable hormone-tracking device to improve how women access and understand their hormonal health. The company, started by Jenny Duan ...

Irvine-based Masimo, which was acquired by Danaher, has received FDA clearance for a monitor feature to detect opioid-induced ...

A major challenge in continuous fetal monitoring is that both the fetus and the umbilical cord are constantly moving. To address this, the researchers developed autonomous tracking algorithms that ...

A look at using trail and wildlife cameras to observe animals in their natural habitat, including camera placement, motion detection, and the unexpected footage these cameras can capture. Watch what ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...

Wearable sweat-sensing technologies are limited by their inability to detect multiple molecular biomarkers, lack of multimodal capabilities, insufficient environmental robustness and the absence of in ...

Policy makers may be able to find middle ground in policies that, rather than eliminating prior authorization completely, put in place guardrails for their use to ensure patients still have access to ...

However, A1C isn’t your only option for tracking your blood sugar levels: Continuous glucose monitors (CGMs) have moved beyond type 1 diabetes care to being an important tool for type 2 management as ...

is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...

Continuous glucose monitoring (CGM) is no longer limited to type 1 diabetes (T1D) and may play a significant role in shaping the care of type 2 diabetes (T2D). Emerging evidence indicates that broader ...

Bridger Management sold 47,841 shares of Masimo in the fourth quarter. The move resulted in the quarter-end position value decreasing by $7.06 million. The position was previously 3.8% of fund AUM as ...